Special Issue "Prevention, Diagnosis and Treatment of Acute Tubulointerstitial Nephritis"
Deadline for manuscript submissions: 20 September 2023 | Viewed by 62
Tubulointerstitial nephritis defines a wide spectrum of acute and chronic inflammatory diseases affecting renal tubules and the interstitium. Inflammation can be the consequence of autoimmune or infectious diseases, but hypersensitivity phenomena involving exposure to drugs are among the most frequent causes. Moreover, novel antitumoral medications acting through immune system modulation may induce tubulointerstitial nephritis. The diagnosis is frequently suspected based on clinical history and presentation, but renal biopsies may reveal specific morphological features and drive the clinical decision. Prognosis is extremely variable as the clinical approach can differ radically based on the etiology, and should include, when possible, removal of the causal agent, requiring immunomodulatory or anti-infectious medications in specific cases.
The aims of this Special Issue include collecting current knowledge about the pathogenesis, diagnosis and treatment of tubulointerstitial nephritis, and providing kidney clinicians and pathologists with novel tools to understand and face this heterogeneous and insidious disease.
This Special Issue will collect original research and review papers on the “epidemiology and clinical outcomes of tubulointerstitial nephritis”, as well as “novel physiopathological insights and novel forms of tubulointerstitial nephritis”, “clinical and histological features” and “therapeutic approaches: pharmacological and non-pharmacological therapies”.
Dr. Marco Delsante
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tubulointerstitial nephritis
- interstitial inflammation
- drug-induced kidney disease
- renal pathology
- acute kidney injury
- immunosuppressive therapy